2022
DOI: 10.1016/j.hpb.2022.07.011
|View full text |Cite
|
Sign up to set email alerts
|

A phase II trial of lanreotide for the prevention of postoperative pancreatic fistula

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…While the efficacy of sealants or of an omental roll-up in preventing postoperative morbidity is still a matter of debate [18][19][20], the use of external drainage of the pancreatic duct showed improved rates of CR-POPF [21][22][23]. Moreover, contrasting results concerning POPF have been achieved using somatostatin analogs [6,24,25].…”
Section: Introductionmentioning
confidence: 99%
“…While the efficacy of sealants or of an omental roll-up in preventing postoperative morbidity is still a matter of debate [18][19][20], the use of external drainage of the pancreatic duct showed improved rates of CR-POPF [21][22][23]. Moreover, contrasting results concerning POPF have been achieved using somatostatin analogs [6,24,25].…”
Section: Introductionmentioning
confidence: 99%